Bengaluru, India

Ramachandran Janakiraman

This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2002-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramachandran Janakiraman. Retrieved from https://idiyas.com/inventor/ramachandran-janakiraman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ramachandran Janakiraman

Introduction

Ramachandran Janakiraman is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of mycobacterial diseases. With a total of 2 patents to his name, his work has the potential to impact public health positively.

Latest Patents

Janakiraman's latest patents include innovative compositions and methods for treating mycobacterial diseases. One of his inventions provides the use of certain isatin and oxindole derivatives in the preparation of a medicament for treating mycobacterial diseases. Another patent focuses on the use of specific succinimide compounds as mycobacterial inhibitors, showcasing his commitment to advancing medical treatments.

Career Highlights

Currently, Janakiraman is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Meenakshi Balganesh and Kantharaj Ethirajulu. Their collaboration fosters a dynamic environment for innovation and discovery in the pharmaceutical sector.

Conclusion

Ramachandran Janakiraman's work exemplifies the spirit of innovation in the medical field. His contributions to the treatment of mycobacterial diseases through his patents highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…